BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Drug Development

  HUYABIO Announces FDA Clearance to Initiate a Phase 1 Trial of SHP2 Inhibitor in Patients with KRAS and EGFR Mutated Tumors

  HUYABIO International announced today the FDA clearance of HBI-2376 as an Investigational New Drug, or IND, for a Phase 1 study.

  October 28, 2021

   · 

  2 min read
• Drug Development

  Meissa Announces Positive Preliminary Clinical Data on Safety and Immunogenicity of Intranasal COVID-19 Vaccine

  Meissa announced today positive preliminary data from the interim analysis of 49 patients in a Phase 1 clinical study of MV-014-212, the company’s intranasal recombinant live attenuated COVID-19 vaccine (ClinicalTrials.gov Identifier: NCT04798001).

  October 28, 2021

   · 

  5 min read
• Business

  McKesson Declares Quarterly Dividend - Oct 28, 2021

  The Board of Directors of McKesson Corporation yesterday declared a regular dividend of 47 cents per share of common stock.

  October 28, 2021

   · 

  1 min read
• Business

  Allogene Therapeutics to Report Third Quarter Financial Results on November 4, 2021

  Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for cancer, today announced that it will report third quarter 2021 financial results on Thursday, November 4, 2021, after the close of the market.

  October 28, 2021

   · 

  2 min read
• Business

  Alnylam Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Period Activity

  Alnylam Pharmaceuticals, Inc. today reported its consolidated financial results for the third quarter ended September 30, 2021 and reviewed recent business highlights.

  October 28, 2021

   · 

  29 min read
• Business

  Heron Therapeutics to Report Third Quarter 2021 Financial Results on Wednesday, November 3, 2021

  Heron Therapeutics, Inc. (Nasdaq: HRTX), today announced that the company will host a conference call and live webcast on Wednesday, November 3, 2021 at 4:15 p.m. ET to report third quarter 2021 financial results and discuss recent business highlights.

  October 28, 2021

   · 

  2 min read
• Cybin Announces Launch of EMBARK Psychedelic Facilitator Training Program

  Cybin Inc. today announced the launch of the EMBARK Psychedelic Facilitator Training Program.

  October 28, 2021

   · 

  7 min read
• Business

  OpGen to Provide Business Update and Financial Results for the Third Quarter 2021 on November 11th at 4:30 p.m. Eastern Time

  OpGen, Inc. announced today that the Company will provide a business update and report its third quarter 2021 financial results after the close of the U.S. financial markets on Thursday, November 11, 2021.

  October 28, 2021

   · 

  1 min read
• Business

  Labcorp Announces 2021 Third Quarter Results

  Labcorp today announced results for the third quarter ended September 30, 2021, and raised full-year guidance.

  October 28, 2021

   · 

  24 min read
• Business

  Baxter Reports Third-Quarter 2021 Results

  Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2021.

  October 28, 2021

   · 

  34 min read